Intellia Therapeutics, INC. (NTLA) — 10-K Filings

All 10-K filings from Intellia Therapeutics, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

Intellia Therapeutics Files 2024 10-K — Feb 27, 2025 Risk: medium
Intellia Therapeutics, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on in vitro an
Intellia Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — Feb 22, 2024 Risk: medium
Intellia Therapeutics, Inc. (NTLA) filed a Annual Report (10-K) with the SEC on February 22, 2024. Intellia Therapeutics, Inc. filed its 2023 Form 10-K on Febru

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX